6 Analysts Assess Doximity: What You Need To Know

Doximity DOCS has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $29.17, a high estimate of $32.00, and a low estimate of $25.00. Marking an increase of 12.19%, the current average surpasses the previous average price target of $26.00.

Diving into Analyst Ratings: An In-Depth Exploration

A comprehensive examination of how financial experts perceive Doximity is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

• Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Doximity. This insight gives a snapshot of analysts' perspectives on the current state of the company.
• Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Doximity compared to the broader market.
• Price Targets: Gaining insights, analysts provide estimates for the future value of Doximity's stock. This comparison reveals trends in analysts' expectations over time.

Capture valuable insights into Doximity's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Doximity analyst ratings.

Discovering Doximity: A Closer Look

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Doximity: A Financial Overview

Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.

Revenue Growth: Doximity displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 17.37%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 35.45%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): Doximity's ROE excels beyond industry benchmarks, reaching 5.52%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Doximity's ROA excels beyond industry benchmarks, reaching 4.73%. This signifies efficient management of assets and strong financial health.

Debt Management: Doximity's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.

Understanding the Relevance of Analyst Ratings

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

This article was generated by Benzinga's automated content engine and reviewed by an editor.